Sign up to save your podcasts
Or
Share E121: Obinutuzumab in SLE-LN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E121: Obinutuzumab in SLE-LN
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
View all episodes
By Michael Putman
4.9
109109 ratings
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
313 Listeners
JAMA Clinical Reviews
488 Listeners
Rheumnow Podcast
113 Listeners
The Curbsiders Internal Medicine Podcast
3,317 Listeners
Core IM | Internal Medicine Podcast
1,071 Listeners
Healio Rheuminations
115 Listeners
Annals On Call Podcast
169 Listeners
The Clinical Problem Solvers
506 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
317 Listeners
ACR on Air
60 Listeners
Around the Rheum
6 Listeners
The Curious Clinicians
365 Listeners
Rheumatology For The Royal College
170 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
19 Listeners